M-Trifluoro-methylphenyl-piperazine

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

544357, C07D29508, C07D29510, A61K 31495

Patent

active

042039860

ABSTRACT:
Compounds of the formula I ##STR1## wherein R.sub.1 represents a hydrogen or fluorine atom, and R.sub.2 represents an alkyl group containing 2 to 6 carbon atoms, or a cycloalkyl or cycloalkyl-alkyl group containing 5 to 8 carbon atoms, each of these groups being substituted by one or two hydroxy groups or an oxo group and, if desired, also by a 4-(m-trifluoromethylphenyl)-piperazino or 4-(3-trifluoromethyl-4-fluoro-phenyl)-piperazino group with the proviso that, when R.sub.1 represents a hydrogen atom, R.sub.2 does not represent a monohydroxyalkyl group, and their pharmaceutically acceptable acid addition salts are novel and have therapeutic use, notably in the region of the central nervous system and in the cardiovascular region.

REFERENCES:
patent: 3170926 (1965-02-01), Ash et al.
patent: 3253989 (1966-05-01), Moser et al.
patent: 3637705 (1972-01-01), Horrom et al.
patent: 3929792 (1975-12-01), Bouchara
patent: 3953449 (1976-04-01), Giudicelli et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

M-Trifluoro-methylphenyl-piperazine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with M-Trifluoro-methylphenyl-piperazine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and M-Trifluoro-methylphenyl-piperazine will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-450345

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.